Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated by global vs individual tumor grading correlate differently with the risk of biochemical recurrence in Grade Group 2 and 3 cancers.
Kryvenko ON, Epstein JI, Merhe A, Iakymenko OA, E Silva RA, Chanamolu DK, Briski LM, Kwon D, Nemov I, Punnen S, Pollack A, Stoyanova R, Parekh DJ, Jorda M, Gonzalgo ML. Kryvenko ON, et al. Among authors: jorda m. Am J Clin Pathol. 2024 Feb 27:aqae003. doi: 10.1093/ajcp/aqae003. Online ahead of print. Am J Clin Pathol. 2024. PMID: 38412318
Metastatic Pleomorphic Lobular Carcinoma of the Breast to the Urinary Bladder: A Report of 10 Cases and Assessment of TRPS1 in the Differential Diagnosis With Plasmacytoid Urothelial Carcinoma.
Zhang GN, Susnik B, Paulsen EJ, Lyons LL, Delma KS, Jorda M, Epstein JI, Kryvenko ON. Zhang GN, et al. Among authors: jorda m. Arch Pathol Lab Med. 2024 Jan 13. doi: 10.5858/arpa.2023-0379-OA. Online ahead of print. Arch Pathol Lab Med. 2024. PMID: 38217332 Free article.
Exploring the atypia of undetermined significance: Malignant ratio, ThyroSeq v3 positive call rate, molecular-derived risk of malignancy, and risk of malignancy as possible quality metric tools in thyroid cytology.
Velez Torres JM, Curnow PM, Tjendra Y, Jorda M, Fernandez CG, Buitrago MG, Zuo Y, Cordero RR. Velez Torres JM, et al. Among authors: jorda m. Cancer Cytopathol. 2024 Apr 9. doi: 10.1002/cncy.22820. Online ahead of print. Cancer Cytopathol. 2024. PMID: 38594180
Atypia of undetermined significance and ThyroSeq v3-positive call rates as quality control metrics for cytology laboratory performance.
Mejia-Mejia O, Bravo-Gonzalez A, Sanchez-Avila M, Tjendra Y, Santoscoy R, Drews-Elger K, Zuo Y, Arias-Abad C, Gomez C, Garcia-Buitrago M, Nadji M, Jorda M, Velez-Torres JM, Ruiz-Cordero R. Mejia-Mejia O, et al. Among authors: jorda m. Cancer Cytopathol. 2024 Apr 9. doi: 10.1002/cncy.22821. Online ahead of print. Cancer Cytopathol. 2024. PMID: 38594192
Low-risk oncocytic renal neoplasm: A useful cytologic diagnosis.
Renshaw AA, Jorda M, Wojcik EM, Pitman MB. Renshaw AA, et al. Among authors: jorda m. Cancer Cytopathol. 2024 Feb;132(2):84-86. doi: 10.1002/cncy.22748. Epub 2023 Jul 31. Cancer Cytopathol. 2024. PMID: 37523299 No abstract available.
Integrative Clinical, Hormonal and Molecular Data associate with Invasiveness in Acromegaly: REMAH Study.
Sampedro-Nuñez M, Herrera-Martínez AD, Ibáñez-Costa A, Rivero-Cortés E, Venegas E, Robledo M, Martínez-Hernández R, García-Martínez A, Gil J, Jordà M, López-Fernández J, Gavilán I, Maraver S, Marqués-Pamies M, Cámara R, Fajardo-Montañana C, Valassi E, Dios E, Aulinas A, Biagetti B, Álvarez Escola C, Araujo-Castro M, Blanco C, de Miguel P, Villar-Taibo R, Álvarez CV, Gaztambide S, Webb SM, Castaño L, Bernabéu I, Picó A, Gálvez MÁ, Soto-Moreno A, Puig-Domingo M, Castaño JP, Marazuela M, Luque RM; REMAH investigators. Sampedro-Nuñez M, et al. Among authors: jorda m. Eur J Endocrinol. 2024 May 3:lvae045. doi: 10.1093/ejendo/lvae045. Online ahead of print. Eur J Endocrinol. 2024. PMID: 38701338
New molecular tools for precision medicine in pituitary neuroendocrine tumors.
Marques-Pamies M, Gil J, Valassi E, Pons L, Carrato C, Jordà M, Puig-Domingo M. Marques-Pamies M, et al. Among authors: jorda m. Minerva Endocrinol (Torino). 2024 Jan 23. doi: 10.23736/S2724-6507.23.04063-0. Online ahead of print. Minerva Endocrinol (Torino). 2024. PMID: 38261299
269 results